Literature DB >> 15785031

Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.

A Sicras1, J Rejas, S Arco, E Flores, G Ortega, A Esparcia, A Suárez, M J Gordillo.   

Abstract

OBJECTIVES: To determine the prevalence of dementia and to measure the monetary impact and health resources utilization of vascular dementia (VD) compared to Alzheimer's dementia (AD) in persons aged over 64 years in a population setting.
METHODS: Retrospective, cross-sectional study. In the initial phase, information was obtained on specific clinical characteristics from the subjects with an active diagnosis of dementia. The second phase consisted of a clinical evaluation and validation of the cases. Mini-Mental State Examination was used to assess cognitive impairment. Dementia and its subtypes were determined using established diagnostic criteria. Information was obtained on the use of health care resources (direct costs) and the number of hours devoted by the primary caregiver (indirect costs) for patients with a documented diagnosis of AD or VD within the last 6 months prior to the interview. A multiple logistic regression analysis was performed to correct the model.
RESULTS: A total of 6,004 subjects were analyzed, 258 with diagnosis of dementia (overall prevalence: 4.3%). An evaluation was made of 224 patients, and gross prevalence of AD and VD was 2.4 and 1.0%, respectively. Cost per patient per semester was EUR 8,086 for AD and EUR 11,039 for VD (p = 0.016). 85.5% of the cost was attributable to primary caregiver time in AD and 84.4% in VD.
CONCLUSIONS: The prevalence of AD and VD increases with age. No sociodemographic differences were seen between AD and VD. Costs associated with health care resource and primary caregiver utilization were high, being higher in VD than in AD.

Entities:  

Mesh:

Year:  2005        PMID: 15785031     DOI: 10.1159/000084556

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  16 in total

Review 1.  Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Authors:  Deborah A Levine; Kenneth M Langa
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.

Authors:  Mary Sano; Carolyn W Zhu; Peter J Whitehouse; Steven Edland; Shelia Jin; Karin Ernstrom; Ronald G Thomas; Leon J Thal; Steven H Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

3.  The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study.

Authors:  Joan Rovira; Guillermina Albarracin; Luis Salvador; Javier Rejas; Eduardo Sánchez-Iriso; Juan M Cabasés
Journal:  Community Ment Health J       Date:  2012-04-08

4.  Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.

Authors:  May A Beydoun; Alyssa A Gamaldo; Hind A Beydoun; Danielle Shaked; Alan B Zonderman; Shaker M Eid
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Economic valuation and determinants of informal care to people with Alzheimer's disease.

Authors:  Luz María Peña-Longobardo; Juan Oliva-Moreno
Journal:  Eur J Health Econ       Date:  2014-05-07

6.  Differences in functional impairment across subtypes of dementia.

Authors:  Tanya Ruff Gure; Mohammed U Kabeto; Brenda L Plassman; John D Piette; Kenneth M Langa
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-12-17       Impact factor: 6.053

7.  Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients.

Authors:  Mireia Massot Mesquida; Frans Folkvord; Gemma Seda; Francisco Lupiáñez-Villanueva; Pere Torán Monserrat
Journal:  BMC Geriatr       Date:  2021-05-22       Impact factor: 3.921

8.  Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease.

Authors:  Joakim Hertze; Sebastian Palmqvist; Lennart Minthon; Oskar Hansson
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-04-19

9.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

10.  Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans.

Authors:  Farzaneh A Sorond; Lewis A Lipsitz; Norman K Hollenberg; Naomi D Ll Fisher
Journal:  Neuropsychiatr Dis Treat       Date:  2008-04       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.